- Home
- FBP vs LGND Comparison
FBP vs LGND Comparison
Compare FBP & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBP | LGND |
|---|---|---|
| Founded | 1948 | 1987 |
| Country | United States | United States |
| Employees | N/A | 68 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.7B |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | FBP | LGND |
|---|---|---|
| Price | $22.64 | $204.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $24.10 | ★ $245.86 |
| AVG Volume (30 Days) | ★ 1.4M | 193.0K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.48% | N/A |
| EPS Growth | ★ 18.78 | N/A |
| EPS | ★ 2.15 | N/A |
| Revenue | ★ $1,255,034,000.00 | N/A |
| Revenue This Year | $15.10 | $1.61 |
| Revenue Next Year | $4.56 | $18.93 |
| P/E Ratio | ★ $10.69 | $76.27 |
| Revenue Growth | ★ 2.38 | N/A |
| 52 Week Low | $17.45 | $98.90 |
| 52 Week High | $23.43 | $227.92 |
Technical Indicators
Market Signals| Indicator | FBP | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 64.85 | 49.86 |
| Support Level | $20.41 | $197.34 |
| Resistance Level | $23.43 | $207.72 |
| Average True Range (ATR) | 0.44 | 7.84 |
| MACD | 0.24 | -0.02 |
| Stochastic Oscillator | 84.58 | 52.97 |
Price Performance
Historical ComparisonAbout FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.